The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men
Abstract
Background The intercellular adhesion molecule ICAM-1 mediates adhesion and transmigration of leucocytes to the vascular endothelial wall, a step proposed to be critical in the initiation and progression of atherosclerosis. Whether concentrations of soluble ICAM-1 (sICAM-1) are raised in apparently healthy individuals who later suffer acute myocardial infarction is unknown.Methods We obtained baseline plasma samples from a prospective cohort of 14,916 healthy men enrolled in the Physicians' Health Study. With a nested case-control design, we measured sICAM-1 concentrations for 474 participants who developed a first myocardial infarction, and 474 controls (participants who remained healthy throughout the 9-year follow-up). Cases were matched to controls according to age and smoking status at the time of myocardial infarction.Findings We found a significant association between increasing concentration of sICAM-1 and risk of future myocardial infarction (p = 0.003), especially among participants with baseline sICAM-1 concentrations in the highest quartile (> 260 ng/mL; relative risk 1.6 [95% Cl 1.1-2.4], p = 0.02). This association was present overall as well as among non-smokers, and persisted after control for lipid and non-lipid risk factors. In multivariate analyses, the risk of future myocardial infarction was 80% higher for participants with baseline sICAM-1 concentrations in the highest quartile (relative risk 1.8 [1.1-2.8], p = 0.02). Similar risk estimates were seen among non-smokers. We found slight but significant correlations between sICAM-1 and fibrinogen, high-density-lipoprotein cholesterol, homocysteine, triglycerides, tissue-type plasminogen-activator antigen, and C-relative protein, but adjustment for these altered the risk little. The risk of myocardial infarction associated with raised concentrations of sICAM-1 seemed to increase with length of follow-up.Interpretation Our data support the hypothesis that cellular mediators of inflammation have a role in atherogenesis and provide a clinical basis to consider antiadhesion therapies as a novel means of cardiovascular disease prevention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“sICAM-1 has been shown to be associated with increased risk of future nonfatal cardiovascular events and incident diabetes. 37,38”
From Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide (2026) · cites this paper as [37]
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618
Adhesion receptors of the immune system
Springer, T. A. (1990) · Nature · doi:10.1038/346425a0 · Cited by 6,477
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Dustin, M. L., Rothlein, R., Bhan, A. K., Dinarello, C. A., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.1.245 · Cited by 2,450
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
Molecular Bases of the Acute Coronary Syndromes
Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,029
Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During Atherogenesis
Cybulsky, M. I., & Gimbrone, M. A. (1991) · Science · doi:10.1126/science.1990440 · Cited by 1,710
Pober, J. S., Gimbrone, M. A., Lapierre, L. A., Mendrick, D. L., Fiers, W., Rothlein, R., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.6.1893 · Cited by 1,413
Davies, M. J., Gordon, J. L., Gearing, A. J. H., Pigott, R., Woolf, N., Katz, D. R., & Kyriakopoulos, A. (1993) · The Journal of Pathology · doi:10.1002/path.1711710311 · Cited by 777
Pigott, R., Dillon, L. P., Hemingway, I., & Gearing, A. J. H. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91234-h · Cited by 650
Cited by
Sorted by citations
Items 601–700 of 999
HMG-CoA Reductase Inhibition: Anti-Inflammatory Effects beyond Lipid Lowering?
März, W., & Wieland, H. (2000) · Herz · doi:10.1007/pl00001949 · Cited by 31
“It is consistent with the concept of atherosclerosis as an inflammatory disease that systemic markers of inflammation such as leukocyte count, C-reactive protein, serum amyloid A, soluble cellular adhesion molecules [33] or interleukin 6 [36] are predictive of cardiovascular disease and clinical events in cross-sectio…”
BackgroundDoo, Y., Han, S.-J., Lee, J., Cho, G.-Y., Hong, K.-S., Han, K., Lee, N., Oh, D., Ryu, K.-H., Rhim, C., et al. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.11.017 · Cited by 31
Inflammatory Cardiovascular Risk Markers in Obstructive Sleep Apnoea Syndrome
Ryan, S., & McNicholas, W. T. (2009) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/187152509787047685 · Cited by 30
“In light of their central role in atherogenesis, CAM’s are promising candidates to reflect vascular inflammation and various studies have suggested that baseline values of CAM’s are predictive of future cardiovascular risk in generally healthy population [79, 80] and associated with adverse events in patients with doc…”
BackgroundBielinski, S. J., Reiner, A. P., Nickerson, D. A., Carlson, C., Bailey, K. R., Thyagarajan, B., Lange, L. A., Boerwinkle, E., Jacobs, D. R., & Gross, M. D. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.02.018 · Cited by 30
“[8] Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J.”
Vaccination against atherosclerosis: An overview
Amirfakhryan, H. (2019) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2019.07.003 · Cited by 30
Knudsen, A., Katzenstein, T. L., Benfield, T., Jørgensen, N. R., Kronborg, G., Gerstoft, J., Obel, N., Kjær, A., & Lebech, A. (2014) · AIDS · doi:10.1097/qad.0000000000000247 · Cited by 30
“In the general population, these markers have been associated with CHD, ranging from early atherosclerosis to fatal MI [39–43].”
BackgroundZhang, C., López‐Ridaura, R., Hunter, D. J., Rifai, N., & Hu, F. B. (2006) · Diabetes · doi:10.2337/db05-1535 · Cited by 30
Goudev, A., Kyurkchiev, S., Gergova, V., Karshelova, E., Georgiev, D. B., Atar, D., Kehayov, I. R., & Nachev, C. (2000) · Cardiology · doi:10.1159/000047322 · Cited by 29
The Role of Risk Factors in the Development of Atherosclerosis
Frohlich, J. J., Dobiášová, M., Lear, S. A., & Lee, K. W. J. (2001) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/20014091084245 · Cited by 30
The TFPI 536C →T Mutation Is not Associated with Increased Risk for Venous or Arterial Thrombosis
Gónzález‐Conejero, R., Lozano, M. L., Corral, J., Martı́nez, C., & Vicente, V. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613911 · Cited by 30
Azar, R. R., Klaymé, S., Germanos, M., Kassab, R., Tawm, S., Aboujaoudé, S., & Naman, R. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00549-6 · Cited by 30
Skerrett, P. J., & Hennekens, C. H. (2005) · Wiley eBooks · doi:10.1002/0470011815.b2a01045 · Cited by 30
The Impact of Obstructive Sleep Apnea and Nasal CPAP on Circulating Adiponectin Levels
Yoshikawa, M., Yamauchi, M., Fujita, Y., Koyama, N., Fukuoka, A., Tamaki, S., Yamamoto, Y., Tomoda, K., & Kimura, H. (2014) · Lung · doi:10.1007/s00408-013-9550-9 · Cited by 29
“Previous studies have provided evidence that atherosclerosis is related to inflammatory processes involving adhesion molecules [6, 8, 9].”
BackgroundPostprandial dysmetabolism: Too early or too late?
Pappas, C., Kandaraki, E., Tsirona, S., Kountouras, D., Kassi, G., & Diamanti‐Kandarakis, E. (2016) · HORMONES · doi:10.14310/horm.2002.1697 · Cited by 30
Bytautiene, E., Tamayo, E. H., Kechichian, T. B., Drever, N. N., Gamble, P., Hankins, G. D. V., & Saade, G. R. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.02.031 · Cited by 29
Kunutsor, S. K., Bakker, S. J. L., & Dullaart, R. P. F. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.38836 · Cited by 29
Rosei, E. A., Morelli, P., & Rizzoni, D. (2005) · Blood Pressure · doi:10.1080/08037050510034257 · Cited by 29
“In fact, it has been demonstrated that adhesion molecule plasma levels may have a prognostic significance in ischaemic heart disease (15–18) as well as in healthy men (19).”
BackgroundPedrinelli, R. (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s4800 · Cited by 29
“Post-MI elevations of circulating TNF-α(92) and MCP-1(93) also associated with an increased risk of recurrent coronary events.(89)”
Haemostatic function, arterial disease and the prevention of arterial thrombosis
MacCallum, P. K., & Meade, T. W. (1999) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.1999.0041 · Cited by 29
John, S., Jacobi, J., Delles, C., Schlaich, M. P., ALTER, O., & Schmieder, R. E. (2000) · Clinical Science · doi:10.1042/cs0980521 · Cited by 29
Heart disease and the inflammatory response
Köenig, W. (2000) · BMJ · doi:10.1136/bmj.321.7255.187 · Cited by 29
Omega-3 Fatty Acids: A Growing Ocean of Choices
Fares, H., Lavie, C. J., DiNicolantonio, J. J., O’Keefe, J. H., & Milani, R. V. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0389-6 · Cited by 31
Savic-Radojevic, A. R., Radovanović, S., Pekmezovic, T. D., Pljesa-Ercegovac, M. S., Simic, D. V., Djukic, T. I., Matic, M. G., & Simic, T. P. (2013) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21570 · Cited by 28
“However, results of studies that investigated the use of ICAM-1 as a biomarker of cardiovascular disease prognosis are contradictory (16, 17).”
BackgroundWu, T., McGrath, K. C. Y., & Death, A. K. (2005) · Vascular Health and Risk Management · doi:10.2147/vhrm.2005.1.4.309 · Cited by 28
“…al 2002), advanced glycation end-points (Smulders et al 1998; Vlassara et al 2003; Lieuw et al 2004), plasma von Willebrand factor and homocysteine (Ridker et al 1998; Jager et al 2000; Targher et al 2001), fibrinogen, and tissue- type plasminogen-activator antigen (Ridker et al 1998), thereby…”
BackgroundInfluentialOmega-3 Fatty Acids Alter Soluble Coronary Heart Disease Patients Markers of Endothelial Function in
Meydani, M. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2000.tb07812.x · Cited by 28
Human cells involved in atherosclerosis have a sex
Franconi, F., Rosano, G. M. C., Basili, S., Montella, A., & Campesi, I. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.118 · Cited by 28
“The levels of soluble ICAM1 in men are better predictors of the risk of myocardial infarction than those in women [306].”
BackgroundLifestyle modification and endothelial function in obese subjects
Hamdy, O. (2005) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.3.2.231 · Cited by 28
Body fat is the main predictor of fibrinogen levels in healthy non-obese men.
Bo, M., Raspo, S., Morra, F., Cassader, M., Isaia, G., & Poli, L. (2004) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2003.12.009 · Cited by 30
Korish, A. A. (2010) · Renal Failure · doi:10.3109/08860221003592820 · Cited by 28
“A significant correlation between sICAM-1 and other inflammatory cytokines as TNF-a and C-reactive protein was reported,([65,66]) suggesting that the circulating level of this molecule may be regarded as a marker of inflammatory process.”
BackgroundEffects of red wine polyphenolic compounds on the cardiovascular system
Zenebe, W. J., & Pecháňová, O. (2002) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03656538 · Cited by 28
“The protective effects of flavonoids in cardiac ischaemia are also associated with their ability to inhibit mast cell secretion, which may be involved in cardiovascular inflammation, at present considered one of the key factors in coronary artery disease ( 44 ).”
Saku, K., Zhang, B., Ohta, T., Shirai, K., Tsuchiya, Y., & Arakawa, K. (1999) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.63.19 · Cited by 28
Kaul, N., Devaraj, S., Grundy, S. M., & Jialal, I. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01534-x · Cited by 28
Kim, H. R., Cho, H. S., Shin, D. Y., & Chung, K. H. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.11.001 · Cited by 27
Menopausal hormone treatment cardiovascular disease: another look at an unresolved conundrum
Harman, S. M. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.02.042 · Cited by 27
Vaverková, H., Karásek, D., Novotný, D., Jackuliaková, D., Halenka, M., Lukeš, J., & Frohlich, J. J. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.07.005 · Cited by 27
Hsu, L., Ko, Y., Wu, S., Teng, M., Chou, H., Chang, C., & Chang, P.-Y. (2009) · Metabolism · doi:10.1016/j.metabol.2009.02.021 · Cited by 27
“Epidemiologic studies have shown that plasma concentrations of sICAM-1 are elevated in patients with unstable angina and myocardial infarction [7,8].”
BackgroundBeckie, T. M., Beckstead, J. W., & Groer, M. E. (2010) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e3181b7e500 · Cited by 27
Blann, A. D., & Lip, G. Y. H. (2003) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200306000-00003 · Cited by 27
Pannacciulli, N., Pergola, G. D., Giorgino, F., & GIORGINO, R. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00770.x · Cited by 27
Dietary lipids and vascular function: UK Food Standards Agency workshop report
Sanderson, P., Olthof, M. R., Grimble, R. F., Calder, P. C., Griffin, B. A., de Roos, N. M., Belch, J. J. F., Muller, D. P. R., & Vita, J. A. (2004) · British Journal Of Nutrition · doi:10.1079/bjn20031034 · Cited by 28
“In subjects without known CVD, soluble intracellular adhesion molecule-1 (Ridker et al. 1998) and tissue plasminogen activator (Thogersen et al.”
BackgroundPluta, W. W., Lubkowska, A., & Dudzińska, W. (2025) · Vascular Health and Risk Management · doi:10.2147/vhrm.s519426 · Cited by 35
Marian, A. J., & Nambi, V. (2004) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.4.6.805 · Cited by 26
The impact of selectins on mortality in stable carotid atherosclerosis
Hoke, M., Winter, M., Wagner, O. F., Exner, M., Schillinger, M., Arnold, Z., Mlekusch, W., Maurer, G., Koppensteiner, R., Minar, E., et al. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-12-1014 · Cited by 26
“showed that increased ICAM-1 levels are associated with future myocardial infarction (6).”
BackgroundResultThe role of Neopterin in cardiovascular disease
Pacileo, M., Cirillo, P. L., Rosa, S. D., Ucci, G., Petrillo, G., D’Amore, S. M., Sasso, L., Maietta, P., Spagnuolo, R., & Massimo Chiariello, A. (2016) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2007.454 · Cited by 26
Anti-inflammatory drugs as promising cardiovascular treatments
Huet, F., Akodad, M., Fauconnier, J., Lacampagne, A., & Roubille, F. (2016) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2017.1273771 · Cited by 26
Cirillo, P. L., Pacileo, M., Rosa, S. D., Calabrò, P., Gargiulo, A., Angri, V., Prevete, N., Fiorentino, I., Ucci, G., Sasso, L., et al. (2007) · Journal of Vascular Research · doi:10.1159/000106464 · Cited by 26
Paulo, M. C., Andrade, A. M., Andrade, M. L., Morais, M. G., Kiely, M. E., Parra, D., Martínez, J. A., Þórsdóttir, I., & Bandarra, N. M. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.11.007 · Cited by 26
“[42] pointed out that the increase in concentrations of sICAM-1 among healthy men is associated with the risk of future CVD events, being a direct mediator of the inflammatory process, not only simply a systemic marker.”
BackgroundHemelaar, M., van der Mooren, M. J., van Baal, W. M., Schalkwijk, C. G., Kenemans, P., & Stehouwer, C. D. A. (2005) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000153888.94399.af · Cited by 26
“72 Serum E2 (pmol/L) 29 (25-41) 28 (23-47) 29 (24-38) 29 (25-48) 0.”
Endothelial function and cardiovascular diseases in HIV infected patient
Andrade, A. C. O., & Cotter, B. R. (2006) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702006000200012 · Cited by 26
Paniagua, J. A., López‐Miranda, J., Pérez‐Martínez, P., Marín, C., Vida, J. M. G., Fuentes, F., de la Puebla, R. Á. F., & Pérez‐Jiménez, F. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01703.x · Cited by 26
Rizzoni, D., Muiesan, M. L., PORTERI, E., Castellano, M., Salvetti, M., Monteduro, C., Ciuceis, C. D., Boari, G. E. M., Valentini, U., Cimino, A., et al. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001570 · Cited by 26
Effects of Hyperinsulinemia on Plasma Levels of Circulating Adhesion Molecules
Jilma, B., Dallinger, S., Hergovich, N., Eichler, H., Richter, V., & Wagner, O. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.5.1748 · Cited by 26
Soluble adhesion molecules and marine n-3 fatty acids in patients referred for coronary angiography
Eschen, O., Christensen, J. H., Toft, E., & Schmidt, E. B. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.12.006 · Cited by 25
Vieira, R. A. L., de Freitas, R. N., & Volp, A. C. P. (2014) · PubMed · doi:10.3305/nh.2014.30.2.7416 · Cited by 25
Rostampour, N. (2017) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2017/26623.10541 · Cited by 25
Howe, C. G., Li, Z., Zens, M. S., Palys, T. J., Chen, Y., Channon, J. Y., Karagas, M. R., & Farzan, S. F. (2017) · Journal of Nutrition · doi:10.3945/jn.117.253419 · Cited by 25
Biochemical risk markers: a novel area for better prediction of renal risk?
Stuveling, E. M., Bakker, S. J. L., Hillege, H. L., de Jong, P. E., Gans, R. O. B., & de Zeeuw, D. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh680 · Cited by 25
Essick, E. E., Sithu, S. D., Dean, W., & D’Souza, S. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9776-7 · Cited by 25
The possible role of red blood cell microvesicles in atherosclerosis
Blum, A. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2008.06.001 · Cited by 25
“In patients with atherosclerosis, protein markers of inflammation are measurable on white blood cells and in sera, and may identify increased risk of future cardiovascular events [22–37].”
BackgroundControversy in Diagnosis and Management of the Metabolic Syndrome
Brietzke, S. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2007.06.005 · Cited by 25
Lee, H. A., Choi, E. J., Park, B., Lee, H., Hong, Y. S., Kim, H. S., Shin, M.-K., & Park, H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233469 · Cited by 24
“Studies have shown that ICAM-1 and VCAM-1 levels are elevated in patients with atherosclerosis, and the baseline ICAM-1 level is reportedly significantly associated with incident myocardial infarction [21] and carotid atherosclerosis [22].”
BackgroundTraditional herbal remedies that influence cell adhesion molecule activity
Spelman, K., Aldag, R., Hamman, A., Kwasnik, E. M., Mahendra, M. A., Obasi, T. M., Morse, J. K., & Williams, E. J. (2010) · Phytotherapy Research · doi:10.1002/ptr.3350 · Cited by 24
“Molecules such as intracellular adhesion molecule 1 (ICAM-1) are increased with the release of various proinflammatory cytokines from Th2 lymphocytes (Ridker et al., 1998).”
BackgroundRallidis, L. S., Gika, H. I., Zolindaki, M., Xydas, T., Paravolidakis, K. E., & Velissaridou, A. H. (2003) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.07.029 · Cited by 24
van Tits, L. J. H., Jacobs, E. M. G., Swinkels, D. W., Lemmers, H., van der Vleuten, G. M., Graaf, J. D., & Stalenhoef, A. F. H. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.08.012 · Cited by 24
“Previously, Ridker et al. found a significant association between increasing concentration of sICAM-1 and risk of future myocardial infarction in apparently healthy men [34].”
Tumour necrosis factor-α, inflammatory biomarkers, and atherogenesis
Blake, G. (2002) · European Heart Journal · doi:10.1053/euhj.2001.2905 · Cited by 24
High-density lipoprotein levels and risk of cardiovascular events
Mureddu, G. F., Brandimarte, F., & Luca, L. D. (2011) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32834bb3c8 · Cited by 26
Protection of Endothelial Function
Spieker, L. E., & Lüscher, T. F. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-27661-0_23 · Cited by 23
Richeux, F. X. E. O., Cascante, M., Ennamany, R., Sanchez, D., Sanni, A., Saboureau, D., & Creppy, E. E. (2000) · Toxicology · doi:10.1016/s0300-483x(00)00184-0 · Cited by 24
Blann, A. D., Lip, G. Y. H., & McCollum, C. N. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00184-3 · Cited by 24
Hillis, G. S., Pearson, C. V., Harding, S. A., Sutherland, S., Ludlam, C. A., Marioni, J. C., Prescott, R. J., Fox, K. A. A., & Flapan, A. D. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.01.016 · Cited by 24
Joy, N. G., Mikeladze, M., Younk, L. M., Tate, D. B., & Davis, S. N. (2016) · Metabolism · doi:10.1016/j.metabol.2016.09.001 · Cited by 23
“ICAM-1 and VCAM-1 are vascular adhesion molecules involved in atherosclerotic development [31, 32].”
BackgroundKarhunen, V., Gill, D., Huang, J. V., Bouras, E., Malik, R., Ponsford, M., Ahola‐Olli, A., Papadopoulou, A., Palaniswamy, S., Sebert, S. P., et al. (2023) · BMJ Medicine · doi:10.1136/bmjmed-2022-000157 · Cited by 23
“30 Comparison with other studies To better understand cytokine regulatory networks, we also examined the associations of genetically predicted circulating cytokines with levels of other cytokines.”
BackgroundRuef, J., März, W., & Winkelmann, B. R. (2006) · Scandinavian Cardiovascular Journal · doi:10.1080/14017430600925300 · Cited by 23
“In addition, markers such as CRP, P-selectin and ICAM-1 are indicative of future cardiovascular events (9,10,11).”
BackgroundAngiogenic Factors in Women Ten Years after Severe Very Early Onset Preeclampsia
Gaugler-Senden, I. P. M., Tamsma, J. T., van der Bent, C., Kusters, R., Steegers, E. A. P., & de Groot, C. J. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043637 · Cited by 23
“They found an increased concentration of ICAM-1, which is an adhesion molecule involved in monocyte attachment and transformation to macrophages in the vascular wall and appears an independent predictor of coronary heart disease [13].”
BackgroundEffects of omega-3 fatty acids on postprandial triglycerides and monocyte activation
Schirmer, S. H., Werner, C., Binder, S. B. G., Faas, M. E., Custodis, F., Böhm, M., & Laufs, U. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.09.002 · Cited by 23
“Asa surrogateparameter,westudied levelsof sICAM1, which are known to reflect endothelial activation and to predict future cardiovascular events [28], and 8-isoprostane and MDA as markers of oxidative stress.”
BackgroundLevels of inflammatory markers and their correlation with dyslipidemia in diabetics.
Waheed, P., Naveed, A. K., & Farooq, F. (2009) · PubMed · Cited by 22
Liu, R.-N. G., Cheng, Q., Zhou, H., Li, B., & Dong-qing, Y. (2019) · Immunological Investigations · doi:10.1080/08820139.2019.1624769 · Cited by 23
“Interestingly, patients with coronary artery diseases have elevated circulating ICAM-1, which may in turn implicate in the initiation and progression of atherosclerosis (Ridker et al., 1998).”
BackgroundFotis, L., Giannakopoulos, D., Stamogiannou, L., & Xatzipsalti, M. (2012) · HORMONES · doi:10.14310/horm.2002.1340 · Cited by 23
Ehrensperger, E., Minuk, J., Durcan, L., Mackey, A., Wolfson, C. M., Fontaine, A. M., & Côté, R. (2005) · Cerebrovascular Diseases · doi:10.1159/000088985 · Cited by 23
“Increased levels of circulating sICAM-1 in healthy subjects and those with coronary heart disease have been shown to predict adverse vascular events [”
BackgroundGourdy, P., Mallat, Z., Castano, C., Garmy-Susini, B. H., Gregor, J. L. M., Tedgui, A., Arnal, J., & Bayard, F. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00322-2 · Cited by 23
Paiker, J. E., Raal, F. J., Veller, M., von Arb, M., Chetty, N., & Naran, N. H. (2000) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00220-x · Cited by 23
Scott, D. A., Poston, R. N., Wilson, R. F., Coward, P. Y., & Palmer, R. M. (2005) · Inflammation Research · doi:10.1007/s00011-004-1335-4 · Cited by 22
Peck, M. J., Sanders, E. B., Scherer, G., Lüdicke, F., & Weitkunat, R. (2018) · Biomarkers · doi:10.1080/1354750x.2017.1419284 · Cited by 21
Krajina, I., Stupin, A., Šola, M., & Mihalj, M. (2022) · Antioxidants · doi:10.3390/antiox11071269 · Cited by 25
Soluble cell adhesion molecules in late-life depression
Thomas, A. J., Morris, C. M., Davis, S., Jackson, E., Harrison, R., & O'Brien, J. T. (2007) · International Psychogeriatrics · doi:10.1017/s1041610206004728 · Cited by 22
“These diseases involve an inflammatory response (Ross, 1993), including increases in serum soluble cell adhesion molecules (Ridker et al., 1998) and cytokines (Ridker et al., 2000).”
BackgroundThe Effects of Stress at Work and at Home on Inflammation and Endothelial Dysfunction
Non, A. L., Rimm, E. B., Kawachi, I. I., Rewak, M., & Kubzansky, L. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094474 · Cited by 22
“Epidemiological studies suggest different roles for these molecules in atherosclerosis, where sICAM-1 may be strongly associated with CHD risk in healthy populations [29] while sVCAM-1 is more strongly associated with disease progression [30].”
BackgroundElevated levels of ferritin and hs-CRP in type 2 diabetes.
Alam, F., Fatima, F., Orakzai, S., Iqbal, N. T., & Fatima, S. S. (2014) · PubMed · Cited by 22
Camaj, P. R., Graziano, J. H., Preteni, E., Popovać, D., LoIacono, N. J., Balac, O., & Factor-Litvak, P. R. (2018) · Journal of Environmental and Public Health · doi:10.1155/2018/3180487 · Cited by 22
de Mello, V. D., Dahlman, I. A., Lankinen, M. A., Kurl, S., Pitkänen, L., Laaksonen, D. E., Schwab, U., & Erkkilä, A. T. (2019) · Nutrition and Diabetes · doi:10.1038/s41387-018-0069-2 · Cited by 22
Kanai, A., Kawamura, T., Umemura, T., Nagashima, M., Nakamura, N., Nakayama, M., Sano, T., Nakashima, E., Hamada, Y., Nakamura, J., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.07.006 · Cited by 22
Micco, P. D. (2009) · International Journal of General Medicine · doi:10.2147/ijgm.s5178 · Cited by 22
Post-stroke inflammatory response: Effects of stroke evolution and outcome
Tan, K. T., Lip, G. Y. H., & Blann, A. D. (2003) · Current Atherosclerosis Reports · doi:10.1007/s11883-003-0046-6 · Cited by 22
“In cardiovascular disease in general, a consensus on their value has yet to appear [38], although ICAM-1 seems to hold some potential [ 39 ,40], as is discussed in the following text.”
BackgroundEmpen, K., Frost, R., Geiss, H., Otto, C., & Parhofer, K. (2003) · Cardiovascular Diabetology · doi:10.1186/1475-2840-2-17 · Cited by 22
“There is strong evidence that the concentration of intercellular adhesion molecule1 (ICAM-1) correlates positively with future cardiovascular risk in healthy men [9].”
BackgroundWalcher, D., & Marx, N. (2004) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2004.011 · Cited by 22
Labarrere, C. A., Ortíz, M. A., Sosa, M. J., Campaña, G., Wernicke, M., Baldridge, L. A., Terry, C. L., & DiCarlo, H. L. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.12.090 · Cited by 22
The biology, utilization, and attenuation of C-reactive protein in cardiovascular disease: Part II
Armani, A. M., & Becker, R. C. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.12.032 · Cited by 22
Soluble Adhesion Molecules: Surrogate Markers of Cardiovascular Disease?
Meydani, M. (2003) · Nutrition Reviews · doi:10.1301/nr.2003.febr.63-68 · Cited by 22
The Effect of Pain on Leukocyte Cellular Adhesion Molecules
Griffis, C. A., Compton, P. A., & Doering, L. V. (2006) · Biological Research For Nursing · doi:10.1177/1099800405286071 · Cited by 21
The ICAM-1 K469E polymorphism is associated with the risk of coronary artery disease
Li, D., Qu, C., & Dong, P. (2014) · Coronary Artery Disease · doi:10.1097/mca.0000000000000136 · Cited by 21
Farzan, S. F., Brickley, E. B., Li, Z., Gilbert‐Diamond, D., Gossai, A., Chen, Y., Howe, C. G., Palys, T. J., & Karagas, M. R. (2017) · Environmental Research · doi:10.1016/j.envres.2017.03.056 · Cited by 21
“(Blankenberg et al., 2001; Ridker et al., 1998) Recent work has indicated that women who experience cardiovascular complications or hypertensive disorders in pregnancy Table 3”
Metadata
- Authors
- Ridker, P. M., Hennekens, C. H., Roitman-Johnson, B., Stampfer, M. J., & Allen, J.
- Affiliations
- Brigham and Women's Hospital (US)
- R&D Systems (United States) (US)
- Corresponding author
- Ridker, Paul M
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1998-01
- Volume
- 351
- Issue
- 9096
- Pages
- 88-92
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2138809584
- Cited by
- 1,229
- References
- 35
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 8 · 2023: 10 · 2022: 16 · 2021: 16 · 2020: 17 · 2019: 23 · 2018: 14 · 2017: 28 · 2016: 27 · 2015: 25 · 2014: 38 · 2013: 27 · 2012: 36
- FWCI
- 26.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- soluble intercellular adhesion molecule-1, sICAM-1, myocardial infarction, atherosclerosis, inflammation, endothelial cell adhesion, anti-adhesion therapy, cardiovascular risk, fibrinogen, homocysteine, tissue plasminogen activator, C-reactive protein, healthy men, Physicians' Health Study
- MeSH terms
- Antioxidants, Arteriosclerosis, Aspirin, Double-Blind Method, Humans, Male, Middle Aged, Myocardial Infarction, Platelet Aggregation Inhibitors, Prospective Studies, Risk Factors, Multivariate Analysis, Case-Control Studies, Intercellular Adhesion Molecule-1, beta Carotene
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review